Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
Clinical trial NCT03721172 · COMPLETED
Trial details
- NCT number
- NCT03721172
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2020-03-06
- Enrollment
- 595
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.